Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Stockholders Equity of $508.59 million for the year ending 2025.
- Ginkgo Bioworks Holdings, Inc. showed a decrease of -29.0% in Stockholders Equity from 2024 to 2025.
- This data is from Ginkgo Bioworks Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $5.00 million | Q2 2021: $5.00 million | Q3 2021: $1.55 billion | Q1 2022: $1.58 billion | Q2 2022: $1.54 billion | Q3 2022: $1.43 billion | Q2 2024: $833.07 million | Q3 2024: $797.94 million | Q2 2025: $612.95 million | Q3 2025: $559.78 million.
- Over the full 6 years of available data (2020 to 2025), Ginkgo Bioworks Holdings, Inc.'s Stockholders Equity has grown by 10.2%.
- Historical annual values: Fiscal year 2025: $508.59 million | Fiscal year 2024: $716.06 million | Fiscal year 2023: $1.10 billion | Fiscal year 2022: $1.74 billion | Fiscal year 2021: $1.51 billion | Fiscal year 2020: $461.38 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: